Form D · Other Health Care

Elligo Health Research, Inc.

Austin, TX · CIK 0001764099

Offering snapshot reported May 9, 2019 · SEC filing

Reported sold
$20M
Offering amount: $20M
Investors reported
19
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
May 2, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 9, 2019Initial$19,999,999No comparison19SEC filing
Jan 25, 2019Initial$5,272,220No comparison16SEC filing
Jan 25, 2019Initial$16,203,892No comparison19SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-339217

Source: Form D, filed May 9, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jacylyn Bodmer Executive
John Crumpler Director
Karen Flaherty Executive
Wyche Green, Iii Director
Christian Lange Director
Chad Moore Executive
Allen Moseley Director
John Potthoff Director, Executive
Thomas Schnettler Director
Amy Staedtler Executive
Scott Treiber Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
11612 Bee Cave Road, Bldg. 1 Suite 150
Austin, TX, 78738